Wegovy Nausea and Vomiting: Separating Myth from Reality

Nausea and vomiting are well-documented with semaglutide (Wegovy) and are caused by the medicine slowing gastric emptying — the stomach empties more slowly than usual, which triggers the sensation of fullness and, in some people, queasiness.
Symptoms are most intense around dose increases and typically ease within a few days to two weeks as your body adapts; they do not usually persist throughout treatment at a steady intensity.
Severe or persistent vomiting, especially alongside abdominal pain, is a signal to seek medical help promptly, it should not be waited out at home.
Suspected side effects can be reported directly to the MHRA via the Yellow Card scheme, patients can report, not just clinicians.

Nausea is the most commonly reported side effect of Wegovy (semaglutide), affecting the majority of people at some point during treatment — but the experience is rarely as relentless as people fear before they start. Most nausea is mild, peaks in the first few days after a dose or dose increase, and settles as the body adjusts. Wegovy is a prescription-only medicine: a GPhC-registered prescriber assesses your suitability before any treatment is issued, and that consultation is the right time to talk through exactly what to expect.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The facts behind nausea on Wegovy, and how to manage it safely

The biggest misconception: nausea means the treatment is harming you

The most common thing people get wrong about GI side effects on semaglutide is reading them as a sign something has gone wrong. Nausea is a direct, predictable consequence of how the medicine works: semaglutide activates GLP-1 receptors that slow gastric emptying, reduce appetite and increase the feeling of fullness. A slower-emptying stomach produces queasiness in many people, particularly when the dose is new or has just increased. It is a pharmacological effect, not damage.

That framing matters because the instinct to stop treatment at the first bout of nausea is very common, and often unnecessary. The NHS patient information for semaglutide lists nausea, vomiting, diarrhoea and constipation as the most frequently reported effects, and notes that they are generally most noticeable early on. The graduated dose schedule (starting low and increasing slowly) exists precisely to give the body time to adjust and to reduce the severity of these effects. Stopping and restarting often resets that adjustment process.

That said, normalising the experience does not mean ignoring it. There is a meaningful difference between mild queasiness that inconveniences you and vomiting that prevents you from eating or drinking. One requires practical management; the other requires clinical input.

What mild-to-moderate nausea actually looks like, and what helps

For most people, nausea on Wegovy is a background discomfort rather than an acute illness. It tends to arrive in the two or three days after an injection, particularly the first injection at each dose level. By the time the next weekly dose is due, the worst has usually passed. A few things make it noticeably worse: eating large portions, eating very quickly, lying down immediately after meals, and consuming high-fat or rich foods. Fatty food slows gastric emptying independently of the medicine; combining the two effects is a reliable way to feel awful.

Practical adjustments that many people find genuinely useful: smaller meals eaten slowly, bland foods in the first couple of days post-injection, cold or room-temperature drinks rather than hot ones, and sitting upright for at least thirty minutes after eating. Ginger in any form (tea, biscuits, capsules) has reasonable evidence for mild nausea, though it is not a substitute for clinical advice. Staying well hydrated matters, vomiting causes fluid loss faster than most people compensate for.

Our prescribers discuss individual side-effect management as part of the clinical review. For a broader picture of how semaglutide affects the body beyond the GI tract, the full Wegovy side-effect overview covers the complete profile. If you want to know what the available support looks like before committing to anything, here is more about how we work.

When vomiting on Wegovy needs medical attention, not home remedies

Vomiting that is persistent, forceful or accompanied by other symptoms sits in a different category. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, if infrequent, serious side effect of GLP-1 medicines including semaglutide. The warning symptom is severe stomach pain, pain that can spread to the back and may or may not come with vomiting. That particular combination should prompt same-day medical attention, not a call to a pharmacy helpline.

Other scenarios that warrant prompt medical review: vomiting that continues for more than 24 hours, an inability to keep any fluids down (dehydration can affect kidney function), signs of an allergic reaction such as swelling of the face or throat, and any symptoms that feel disproportionate to what you expected. If in doubt, contact your GP or call NHS 111.

For those specifically dealing with persistent or disruptive vomiting, practical guidance on managing vomiting on Wegovy is available, and there is a separate page on vomiting bile on Wegovy for people experiencing that particular variant. These are not uncommon questions, our prescribers hear them regularly.

The combined diarrhoea and vomiting pattern is covered separately, because the fluid-loss considerations are different when both are happening at once.

Starting treatment knowing what to expect

Understanding the side-effect profile before the first pen arrives makes a significant difference to how people experience early treatment. That plain box from DPD will include a Patient Information Leaflet, reading it fully, not just skimming the dose instructions, is worth the ten minutes.

Wegovy is a prescription-only medicine. Any legitimate supply requires a clinical assessment by a qualified prescriber; that assessment is not a formality. At nume, a GPhC-registered Independent Prescriber reads your consultation responses personally, which means side-effect risk factors, current medicines and relevant medical history all get considered before any prescription is issued. To explore whether Wegovy could be appropriate for you, you can learn more about it on our Wegovy overview or read about the full range of options on the weight-loss treatment page. Cost is often a question at this stage too, the Wegovy pricing page sets out what is included in a private prescription route.

If you are ready to take the next step, check your eligibility with a free consultation. Our prescribers discuss suitability and side effects as part of every review.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions